Mallinckrodt Restructures Its Spinoff And Completes Management Team

Mallinckrodt has altered the composition of the Specialty Generics business that it plans to spin off by the end of this year, removing its Amitiza brand. The firm says it now has a “full management team in place” for the Specialty Generics unit after naming Eric Slusser as chief financial officer, to serve under president and CEO Matthew Harbaugh.

Spin
Mallinckrodt is aiming to reap rewards with the spinoff of its generics business • Source: Shutterstock

Mallinckrodt’s Amitiza (lubiprostone) brand will no longer form part of the Specialty Generics unit that the firm plans to spin off in the second half of 2019, under revised plans that have just been announced by the company.

“Given the strong, return-to-growth performance of the Specialty Generics business, it has been determined that the Amitiza product should remain...

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Strategy

More from Business